| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US363206AUS3860645A (en) | 1973-05-23 | 1973-05-23 | Bacteriostatic substituted carbanilides |
| Publication Number | Publication Date |
|---|---|
| ATA426874A ATA426874A (en) | 1976-09-15 |
| AT336631Btrue AT336631B (en) | 1977-05-10 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT426874AAT336631B (en) | 1973-05-23 | 1974-05-22 | PROCESS FOR MANUFACTURING NEW DIPHENYLURA |
| Country | Link |
|---|---|
| US (1) | US3860645A (en) |
| JP (1) | JPS5047941A (en) |
| AT (1) | AT336631B (en) |
| AU (1) | AU476065B2 (en) |
| BE (1) | BE815418A (en) |
| CA (1) | CA1026769A (en) |
| CH (1) | CH586194A5 (en) |
| DE (1) | DE2422243A1 (en) |
| FR (1) | FR2230627B1 (en) |
| GB (1) | GB1413449A (en) |
| IL (1) | IL44410A (en) |
| NL (1) | NL7405417A (en) |
| ZA (1) | ZA741631B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2928485A1 (en)* | 1979-07-14 | 1981-01-29 | Bayer Ag | USE OF UREA DERIVATIVES AS A MEDICINAL PRODUCT IN THE TREATMENT OF FATTY METABOLISM DISORDERS |
| JPH0395153A (en)* | 1989-06-15 | 1991-04-19 | Mitsubishi Kasei Corp | Diphenyl urea derivative |
| US6344476B1 (en)* | 1997-05-23 | 2002-02-05 | Bayer Corporation | Inhibition of p38 kinase activity by aryl ureas |
| US20080300281A1 (en)* | 1997-12-22 | 2008-12-04 | Jacques Dumas | Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas |
| US7329670B1 (en)* | 1997-12-22 | 2008-02-12 | Bayer Pharmaceuticals Corporation | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas |
| US7517880B2 (en)* | 1997-12-22 | 2009-04-14 | Bayer Pharmaceuticals Corporation | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| US20080269265A1 (en)* | 1998-12-22 | 2008-10-30 | Scott Miller | Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas |
| US8124630B2 (en)* | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| ME00275B (en)* | 1999-01-13 | 2011-02-10 | Bayer Corp | ?-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| IL144144A0 (en)* | 1999-01-13 | 2002-05-23 | Bayer Ag | Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| US7928239B2 (en) | 1999-01-13 | 2011-04-19 | Bayer Healthcare Llc | Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas |
| WO2000042012A1 (en) | 1999-01-13 | 2000-07-20 | Bayer Corporation | φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS |
| US7235576B1 (en) | 2001-01-12 | 2007-06-26 | Bayer Pharmaceuticals Corporation | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US7371763B2 (en)* | 2001-04-20 | 2008-05-13 | Bayer Pharmaceuticals Corporation | Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| CA2468463C (en)* | 2001-12-03 | 2013-06-18 | Bayer Pharmaceuticals Corporation | Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| US20080108672A1 (en)* | 2002-01-11 | 2008-05-08 | Bernd Riedl | Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors |
| EP1478358B1 (en)* | 2002-02-11 | 2013-07-03 | Bayer HealthCare LLC | Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis |
| WO2003068223A1 (en)* | 2002-02-11 | 2003-08-21 | Bayer Corporation | Aryl ureas with raf kinase and angiogenesis inhibiting activity |
| WO2003068229A1 (en)* | 2002-02-11 | 2003-08-21 | Bayer Pharmaceuticals Corporation | Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors |
| ATE529406T1 (en)* | 2002-02-11 | 2011-11-15 | Bayer Healthcare Llc | ARYL UREAS AS KINASE INHIBITORS |
| US7557129B2 (en)* | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| US8796250B2 (en)* | 2003-05-20 | 2014-08-05 | Bayer Healthcare Llc | Diaryl ureas for diseases mediated by PDGFR |
| DE602004010407T2 (en)* | 2003-07-23 | 2008-10-16 | Bayer Pharmaceuticals Corp., West Haven | FLUORO-SUBSTITUTED OMEGA-CARBOXYARYLDIPHENYL-UREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND SUFFERING |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2818930A (en)* | 1948-08-07 | 1958-01-07 | Joseph B Kucera | Three-wheeled vehicle having a high arched front frame |
| US2745874A (en)* | 1953-06-18 | 1956-05-15 | Geigy Ag J R | Insecticidal derivatives of diphenyl urea |
| US2846398A (en)* | 1955-12-27 | 1958-08-05 | Monsanto Chemicals | Antiseptic detergent composition |
| Publication number | Publication date |
|---|---|
| NL7405417A (en) | 1974-11-26 |
| BE815418A (en) | 1974-11-22 |
| FR2230627B1 (en) | 1977-09-30 |
| AU476065B2 (en) | 1976-09-09 |
| US3860645A (en) | 1975-01-14 |
| CA1026769A (en) | 1978-02-21 |
| FR2230627A1 (en) | 1974-12-20 |
| DE2422243A1 (en) | 1974-12-12 |
| IL44410A (en) | 1977-10-31 |
| GB1413449A (en) | 1975-11-12 |
| ZA741631B (en) | 1975-01-29 |
| IL44410A0 (en) | 1974-06-30 |
| AU6665074A (en) | 1975-09-18 |
| ATA426874A (en) | 1976-09-15 |
| CH586194A5 (en) | 1977-03-31 |
| JPS5047941A (en) | 1975-04-28 |
| Publication | Publication Date | Title |
|---|---|---|
| AT336631B (en) | PROCESS FOR MANUFACTURING NEW DIPHENYLURA | |
| DD110652A5 (en) | PROCESS FOR PREPARING NEW 1-ARYLOXY-2-HYDROXY-3-ALKINYLAMINEOPROPANE | |
| ATA504374A (en) | PROCESS FOR PRODUCING NEW HAPTENSTEROIDS | |
| ATA588973A (en) | PROCESS FOR PRODUCING NEW PHENOXYPROPANOLAMINE | |
| ATA639275A (en) | PROCESS FOR MANUFACTURING NEW RIFAMYCINE | |
| AT341118B (en) | METHOD FOR PRODUCING NEW DOTRACONTAPEPTIDAMIDE | |
| ATA208576A (en) | PROCESS FOR PRODUCING NEW ALFA-ATHYLBENZHYDROL DERIVATIVES | |
| AT337165B (en) | PROCESS FOR PRODUCING NEW PHENYLPROPENYLAMINE DERIVATIVES | |
| AT334365B (en) | PROCESS FOR PRODUCING NEW THIAZOL-5-METHANOL DERIVATIVES | |
| AT326653B (en) | PROCESS FOR PRODUCING NEW 2-AMINO-4-H-PYRANES | |
| AT328084B (en) | PROCESS FOR MANUFACTURING NEW ANTIBIOTICS | |
| AT338245B (en) | PROCESS FOR PRODUCING NEW ARYLOXYALKYL LIKETONS | |
| AT327881B (en) | PROCESS FOR PRODUCING NEW FURANDERIVATES | |
| AT331224B (en) | PROCESS FOR MANUFACTURING NEW ALFA-CARBOXY-BENZYLSULPHONE REESTERS | |
| AT333950B (en) | PROCESS FOR PRODUCING NEW CEPHAM CONNECTIONS | |
| AT347032B (en) | PROCESS FOR MANUFACTURING NEW ANTIBIOTICS | |
| ATA678876A (en) | PROCESS FOR MANUFACTURING NEW ANTIBIOTICS | |
| AT336200B (en) | PROCESS FOR PRODUCING NEW CARDENOLIDACETALS | |
| ATA986376A (en) | PROCESS FOR PRODUCING NEW HAPTENSTEROIDS | |
| AT342028B (en) | PROCESS FOR THE PREPARATION OF NEW CHLORACETANILIDE | |
| AT340404B (en) | PROCESS FOR PRODUCING NEW BENZOYLBENZOCYCLOALKENE | |
| AT322542B (en) | PROCESS FOR PRODUCING NEW NITROFURANIC COMPOUNDS | |
| ATA435577A (en) | PROCESS FOR PREPARING NEW PHENYLBUTENONE | |
| AT345484B (en) | METHOD FOR PRODUCING NEW DOTRACONTAPEPTIDAMIDE | |
| ATA158875A (en) | METHOD FOR PRODUCING NEW PSEUDOTRISACCHARID |
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |